Diversified Consumer Services
Company Overview of University of Liverpool
University of Liverpool is an educational institution. The institution is based in Liverpool, United Kingdom.
University of Liverpool
Liverpool, L69 3BX
Founded in 1881
Key Executives for University of Liverpool
Director of Business Services
Compensation as of Fiscal Year 2014.
University of Liverpool Key Developments
University of Liverpool and Unilever Announce Opening of GBP 65 Million Materials Innovation Factory
Jun 27 14
The University of Liverpool and Unilever have announced the opening of GBP 65 million Materials Innovation Factory, or MIF, to accelerate research and reduce new product development times relevant to a range of sectors including Unilever's home care and personal care categories. The MIF will provide equipment at the cutting-edge of materials chemistry research, which will accelerate manufacturing processes and allow the discovery of new materials. Supported by the Higher Education Funding Council for England, as part of the UK Government's Research Partnership Investment Fund, the MIF is a unique public/private partnership between the University and Unilever. The facility is expected to be occupied by a total of 250 researchers, including University staff, a team of Unilever scientists based at their global R&D (R&D) Centre for Home Care and Personal Care products in Port Sunlight, and a broad range of other industrial and academic partners. The MIF represents another exciting step in Unilever's next generation capability development and will help to deliver bigger and better consumer innovations, whilst accelerating product development process. Construction of the 120,000 sq ft facility on Grove Street in Liverpool is due to commence this September, and is expectced to be fully operational by the summer of 2016.
Eisai Co., Ltd. Enters into Collaboration with Liverpool School of Tropical Medicine and University of Liverpool to Discover Novel Anti-Wolbachia Targeted Anti-Filarial Drugs
Mar 20 14
Eisai Co., Ltd. announced that it has entered a collaboration with the Liverpool School of Tropical Medicine (LSTM) and University of Liverpool (UoL) to jointly identify new drugs effective against lymphatic filariasis and onchocerciasis (river blindness), both major types of filariasis. Under the collaboration, Eisai will work with LSTM and UoL to identify and develop novel drug candidates that efficiently eliminate the bacteria Wolbachia. Eisai and its collaboration partners will focus on two of these six proposed types and aim to identify a single candidate for potential drug development within one to two years. This unique approach was also evaluated and subsequently awarded a two-year grant by the Global Health Innovative Technology Fund.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries